News
ADGM
0.5199
+7.95%
0.0383
Weekly Report: what happened at ADGM last week (0720-0724)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 07/21 21:05
Weekly Report: what happened at ADGM last week (0713-0717)?
Weekly Report · 07/20 09:43
Weekly Report: what happened at ADGM last week (0706-0710)?
Weekly Report · 07/13 09:45
Weekly Report: what happened at ADGM last week (0629-0703)?
Weekly Report · 07/06 09:47
Weekly Report: what happened at ADGM last week (0622-0626)?
Weekly Report · 06/29 09:43
Weekly Report: what happened at ADGM last week (0615-0619)?
Weekly Report · 06/22 09:49
Adagio Medical Advances VT Cryoablation Study, Setting Up a New Cardiac Device Catalyst
TipRanks · 06/17 16:31
Adagio Medical Shareholders Approve Directors and Auditor Ratification
TipRanks · 06/16 22:35
Adagio Medical holds annual stockholder meeting
PUBT · 06/16 21:27
Weekly Report: what happened at ADGM last week (0608-0612)?
Weekly Report · 06/15 09:50
Adagio Medical Faces Nasdaq Minimum Bid Price Noncompliance
TipRanks · 06/12 22:50
Adagio Medical gets Nasdaq notice after shares trade below $1 bid-price minimum
PUBT · 06/12 20:33
Weekly Report: what happened at ADGM last week (0601-0605)?
Weekly Report · 06/08 09:47
Adagio Medical Price Target Announced at $3.00/Share by LUCID CAPITAL MARKETS
Dow Jones · 06/03 18:02
Adagio Medical initiated with a Buy at Lucid Capital
TipRanks · 06/03 11:16
Weekly Report: what happened at ADGM last week (0525-0529)?
Weekly Report · 06/01 09:50
Weekly Report: what happened at ADGM last week (0518-0522)?
Weekly Report · 05/25 09:52
Adagio Files PMA for Breakthrough Ventricular Ablation System
TipRanks · 05/21 23:03
More
Webull provides a variety of real-time ADGM stock news. You can receive the latest news about Adagio Medical through multiple platforms. This information may help you make smarter investment decisions.
About ADGM
Adagio Medical Holdings, Inc. is a medical device company. The Company is focused on developing and commercializing products for the treatment of cardiac arrhythmias with catheter-based ultra-low temperature ablation (ULTA) technology, formerly known as ultra-low temperature cryoablation (ULTC) technology. Its initial focus is on the treatment of ventricular tachycardia (VT), which is a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart’s lower chambers, or ventricles, potentially leading to impaired blood flow and, if sustained, it can be fatal. Its ULTA products are purpose-built to treat patients with VT and are designed to address the unique anatomy of the ventricle and the specific needs of the VT patient. Its catheters and consoles are designed to create titratable, large, durable, deep lesions within the ventricle through a stable, endocardial or inside the heart approach with no required irrigation.